Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1539 Latest Draft

Bill / Introduced Version Filed 03/17/2025

                            I 
119THCONGRESS 
1
STSESSION H. R. 1539 
To amend the Federal Food, Drug, and Cosmetic Act to expand the types 
of devices for which required labeling may be made available solely 
by electronic means, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY24, 2025 
Mr. O
BERNOLTE(for himself, Mr. MULLIN, Mr. CRENSHAW, and Ms. CRAIG) 
introduced the following bill; which was referred to the Committee on En-
ergy and Commerce 
A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
expand the types of devices for which required labeling 
may be made available solely by electronic means, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-1
tives of the United States of America in Congress assembled, 2
SECTION 1. SHORT TITLE. 3
This Act may be cited as the ‘‘Medical Device Elec-4
tronic Labeling Act’’. 5
VerDate Sep 11 2014 03:45 Mar 13, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H1539.IH H1539
kjohnson on DSK7ZCZBW3PROD with $$_JOB 2 
•HR 1539 IH
SEC. 2. ALLOWING REQUIRED LABELING OF DEVICES TO 1
BE MADE AVAILABLE SOLELY BY ELEC-2
TRONIC MEANS. 3
Section 502(f) of the Federal Food, Drug, and Cos-4
metic Act (21 U.S.C. 352(f)) is amended to read as fol-5
lows: 6
‘‘(f)(1) Unless its labeling bears (A) adequate direc-7
tions for use; and (B) such adequate warnings against use 8
in those pathological conditions or by children where its 9
use may be dangerous to health, or against unsafe dosage 10
or methods or duration of administration or application, 11
in such manner and form, as are necessary for the protec-12
tion of users, except that where any requirement of clause 13
(A) of this subparagraph, as applied to any drug or device, 14
is not necessary for the protection of the public health, 15
the Secretary shall promulgate regulations exempting such 16
drug or device from such requirement. 17
‘‘(2) Subject to subparagraph (3), required labeling 18
for devices (including in vitro diagnostic devices) may be 19
made available solely by electronic means, provided that— 20
‘‘(A) such required labeling is readily accessible 21
to intended users of such devices; 22
‘‘(B) the manufacturer affords intended users 23
of such devices the opportunity to request the re-24
quired labeling in paper form, and upon such re-25
VerDate Sep 11 2014 03:45 Mar 13, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H1539.IH H1539
kjohnson on DSK7ZCZBW3PROD with $$_JOB 3 
•HR 1539 IH
quest, promptly provides the requested information 1
in paper form without additional cost; and 2
‘‘(C) the label affixed to the device or its imme-3
diate container includes all information in compli-4
ance with this Act and the regulations thereunder or 5
any applicable order of the Secretary under subpara-6
graph (3)(A). 7
‘‘(3)(A) With respect to devices for which labeling is 8
made available solely by electronic means, the Secretary 9
may issue an order establishing requirements in addition 10
to, or exceptions from, the requirements under subpara-11
graph (2) for the label affixed to a device type. 12
‘‘(B) Notwithstanding subchapter II of chapter 5 of 13
title 5, United States Code, such order shall be published 14
in the Federal Register, following publication of a pro-15
posed order in the Federal Register and consideration of 16
comments to a public docket. 17
‘‘(C) Such order may require the label of a device 18
to contain certain information or comply with certain con-19
ditions only if the Secretary determines such requirement 20
is necessary to provide a reasonable assurance of the safe-21
ty and effectiveness of the device.’’. 22
Æ 
VerDate Sep 11 2014 03:45 Mar 13, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6301 E:\BILLS\H1539.IH H1539
kjohnson on DSK7ZCZBW3PROD with $$_JOB